Health2 days ago
Alnylam Pharmaceuticals Completes $34.4 Million Note Repurchase
Alnylam Pharmaceuticals has announced a significant financial maneuver, reaching agreements to repurchase approximately $34.4 million of its 1.00% Convertible Senior Notes due in 2027. The total...